The efficacy of InterRhythmic care for depression: A randomized control trial

Area of Science:

• Psychiatry
• Clinical Psychology
• Behavioral Science

Background:

• Major Depressive Disorder (MDD) is a prevalent mental health condition with significant impact on quality of life.
• Existing treatments for MDD have limitations, necessitating exploration of novel therapeutic approaches.
• There is a scarcity of clinical research examining the efficacy of InterRhythmic Care (IRC) for MDD.

Purpose of the Study:

• To investigate the efficacy of InterRhythmic Care (IRC) as a treatment for Major Depressive Disorder (MDD).
• To assess the impact of IRC on depressive symptoms, anxiety levels, interpersonal relationships, social function, and biological rhythms in patients with MDD.

Main Methods:

• An eight-week, randomized, single-blind, controlled trial was conducted with 120 MDD patients.
• Participants were assigned to either IRC or Internet general psychoeducation (IGP).
• Symptom severity, interpersonal function, social disability, and circadian rhythms were evaluated using standardized scales (HAMD-17, HAMA, ICDS, SDS, MEQ) at baseline and week 8.

Main Results:

• IRC group showed significantly lower scores on the Hamilton Depression Rating Scale (HAMD-17) and Hamilton Anxiety Scale (HAMA) compared to the IGP group.
• Participants receiving IRC demonstrated significant improvements in interpersonal relationships (ICDS) and social functioning (SDS).
• IRC intervention led to significant positive changes in biological rhythms as measured by the Morning and Evening Questionnaire (MEQ).

Conclusions:

• InterRhythmic Care (IRC) is an effective intervention for improving clinical symptoms in patients with Major Depressive Disorder (MDD).
• IRC demonstrates benefits in reducing depressive and anxiety symptoms.
• The intervention also positively impacts interpersonal problems and enhances overall social function in individuals with MDD.